1α, 25 dihydroxyvitamin D3-dependent up-regulation of calcium-binding proteins in motoneuron cells

Journal of Neuroscience Research

Volumn 51, Issue 1, 1998, Pages 58-66

  Alexianu, Maria E ^a,b   Robbins, Elaine ^c   Carswell, Susan ^c   Appel, Stanley H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c CEPHALON INC   (United States)

Author keywords

1,25 dihydroxyvitamin D3; Amyotrophic lateral sclerosis; Calcium binding proteins

Indexed keywords

CALBINDIN; CALCITRIOL; CALCIUM BINDING PROTEIN; CALRETININ; PARVALBUMIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN VENTRICLE; CALCIUM HOMEOSTASIS; CELL CULTURE; CELL LOSS; CONTROLLED STUDY; DEGENERATIVE DISEASE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MOTONEURON; MOTOR SYSTEM; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DRUG EFFECT; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; METABOLISM; SPINAL CORD; UPREGULATION;

ANIMALS; CALCITRIOL; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CELL LINE; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MOTOR NEURONS; RATS; SPINAL CORD; UP-REGULATION;

EID: 0031594331     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980101)51:1<58::AID-JNR6>3.0.CO;2-K     Document Type: Article

References (45)

1. Alexianu ME, Mohamed AH, Smith RG, Colom LV, Appel SH (1994a): Apoptotic cell death of a hybrid motoneuron cell line induced by immunoglobulins from patients with amyotrophic lateral sclerosis. J Neurochem 63:2365-2368.
2. Alexianu ME, Ho B-K, Mohamed H, LaBella V, Smith RG, Appel SH (1994b): The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol 36:846-858.
3. Appel SH, Engelhardt JI, Garcia J, Stefani E (1991): Immunoglobulins from animal models of motoneuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. Proc Natl Acad Sci USA 88:647-651.
4. Appel SH, Smith RG, Alexianu M, Engelhardt J, Alexianu D, Colom L, Stefani E (1994): Neurodegenerative disease: Autoimmunity involving calcium channels. Ann NY Acad Sci 747:183-194.
5. Berger U, Wilson P, McClelland RA, Colston K, Haussler MRF, Pike JW, Coombes RC (1988): Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clip Endocrinol Metab 67:607-613.
6. Bouillon R, Okamura WH, Norman AW (1995): Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257.
7. 3 receptor in target cells. Endocrinology 122:1224-1230.
8. Colom LV, Alexianu ME, Mosier DR, Smith RG, Appel SH (1997): Amyotrophic lateral sclerosis immunoglobulins increase intracellular calcium in a motoneuron cell line. Exp Neurol 146:354-360.
9. DeViragh PA, Haglid KG, Celio MR (1989): Parvalbumin increases in the putamen of rats with vitamin D hypervitaminosis. Proc Natl Acad Sci USA 86:3887-3890.
10. Engelhardt JI, Siklos L, Komuves L, Smith RG, Appel SH (1995): Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse 20:185-199.
11. 3 regulates γ-glutamyl transpeptidase activity in rat brain. Neurosci Lett 216:183-186.
12. 3- and butyrate-inducible responses. Proc Natl Acad Sci USA 90:2984-2988.
13. 3-dependent calbindin (a 28,000-dalton calcium binding protein) and its mRNA in D-replete and D-deficient chickens. Arch Biochem Biophys 260:645-652.
14. 2+-binding proteins in human neurodegenerative disorders. Trends Neurosci 15:259-264.
15. 28K-like immunoreactivity in catecholaminergic cell groups of the human midbrain: Normal distribution and distribution in Parkinson's disease. Neurodegeneration 1:83-93.
16. 28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity. Proc Natl Acad Sci 93:6796-6801.
17. 3 and dietary alteration. Mol Endocrinol 2:928-935.
18. 28K) gene expression in aging and neurodegenerative diseases. Proc Natl Acad Sci USA 87:4078-4082.
19. 28K) in rat olfactory bulb. Brain Res 578:305-310.
20. Ince P, Stout N, Shaw P, Slade J, Hunziker W, Heizmann CW, Baimbridge KG (1993): Parvalbumin and calbindin D-28k in human motor system and in motor neuron disease. Neuropathol Appl Neurobiol 19:291-299.
21. Kojima H, Inuzuka S, Miwa T, Furukawa S, Hayashi K, Kanegae Y, Saito I, Ohishi N, Takamori M, Yagi K (1995): Construction and characterization of adenoviral vector expressing biologically active brain-derived neurotrophic factor. Biochem Biophys Res Comm 212:712-717.
22. LaBella V, Alexianu ME, Colom LV, Ionescu A, Mohamed AH, Appel SH (1996): Apoptosis induced by β-N-oxalylamino-L-alanine on a motoneuron hybrid cell line. Neuroscience 70:1039-1052.
23. Le Gal La Salle G, Robert JJ, Berrard S, Ridoux V, Stratford-Perrocaudet LD, Pericaudet M, Mallet J (1993): An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259:988-990.
24. Lavoi B, Parent (1991): Dopaminergic neurons expressing calbindin in normal and Parkinsonian monkeys. NeuroReport 1:601-604.
25. 3 prevents the in vivo induction of murine experimental allergic encephalomyelitis. J Clin Invest 87:1103-1107.
26. 3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo. Endocrinology 135:2818-2821.
27. McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988): Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 24:574-576.
28. 3 receptors and estrogen receptors by monoclonal antibodies: Comparison of four immunoperoxidase methods. J Histochem Cytochem 37:1609-1617.
29. 3 receptors: Gene regulation and genetic circuitry. FASEB J 2:3043-3053.
30. 2+ currents in a motoneuron cell line. Ann Neurol 37:102-109.
31. 3 exerts regional effects in the central nervous system during experimental allergic encephalomyellitis. J Neuropathol Exp Neurol 55:904-914.
32. 3. Endocrinology 115:1476-1783.
33. 3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol 41:231-240.
34. 28K, calretinin, calmodulin and parvalbumin in the rat spinal cord. Brain Res Rev 19:163-179.
35. Siklos L, Engelhardt JI, Harati Y, Smith RG, Joo F, Appel SH (1996): Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann Neurol 39:203-216.
36. Smith RG, Alexianu ME, Crawford G, Nyormoi O, Stefani E, Appel SH (1994): The cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc Natl Acad Sci USA 91:3393-3397.
37. 3 sites of action in the brain. Histochem 87:393-406.
38. 3 sites of action in spinal cord and sensory ganglion. Ann Embryol 177:307-310.
39. Schwaller B, Buchwald P, Blumcke I, Celio MR, Hunziker W (1993): Characterization of a polyclonal antiserum against the purified human recombinant calcium-binding protein calretinin. Cell Calcium 14:639-648.
40. 2+ exchange. Endocrinology 123:2765-2776.
41. 2+-dependent processes as mediators of neurotoxicity. NeuroToxicology 13:139-148.
42. 3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res 28:110-114.
43. Yamada T, McGeer PL, McGeer EG (1992): Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins. Acta Neuropathol (Berl) 84:100-104.
44. Yamaguchi T, Keino K, Fukuda J (1995): The effect of insulin-like growth factor-1 on the expression of calretinin and calbindin D-28k in rat embryonic neurons in culture. Neurochem Int 26:255-262.
45. Zhang J-H, Monta Y, Hironaka T, Emsom PC, Tohyama M (1990): Ontological study of calbindin-D28k-like and parvalbumin-like immunoreactivities in rat spinal cord and dorsal root ganslion. J Comp Neurol 302:715-728.